NO20020163D0 - Fremgangsmåte for fremstilling av 2-amino-4-(4-fluorfenyl)-6- alkylpyrimidin-5-karboksylat - Google Patents

Fremgangsmåte for fremstilling av 2-amino-4-(4-fluorfenyl)-6- alkylpyrimidin-5-karboksylat

Info

Publication number
NO20020163D0
NO20020163D0 NO20020163A NO20020163A NO20020163D0 NO 20020163 D0 NO20020163 D0 NO 20020163D0 NO 20020163 A NO20020163 A NO 20020163A NO 20020163 A NO20020163 A NO 20020163A NO 20020163 D0 NO20020163 D0 NO 20020163D0
Authority
NO
Norway
Prior art keywords
sup
formula
amino
preparation
alkyl
Prior art date
Application number
NO20020163A
Other languages
English (en)
Other versions
NO328103B1 (no
NO20020163L (no
Inventor
Ulrich Veith
Original Assignee
Lonza Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lonza Ag filed Critical Lonza Ag
Publication of NO20020163D0 publication Critical patent/NO20020163D0/no
Publication of NO20020163L publication Critical patent/NO20020163L/no
Publication of NO328103B1 publication Critical patent/NO328103B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/34Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/02Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C311/03Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C311/05Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms to acyclic carbon atoms of hydrocarbon radicals substituted by nitrogen atoms, not being part of nitro or nitroso groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20020163A 1999-07-13 2002-01-11 Fremgangsmate for fremstilling av 2-amino-4-(4-fluorfenyl)-6-alkylpyrimidin-5-karboksylater og mellomprodukter derav NO328103B1 (no)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
EP99113711 1999-07-13
EP99120417 1999-10-14
US18546500P 2000-02-28 2000-02-28
US18537100P 2000-02-28 2000-02-28
EP00106303 2000-03-23
PCT/EP2000/006099 WO2001004100A1 (en) 1999-07-13 2000-06-30 Process for preparing 2-amino-4-(4-fluorphenyl)-6-alkylpyrimidine-5-carboxylate

Publications (3)

Publication Number Publication Date
NO20020163D0 true NO20020163D0 (no) 2002-01-11
NO20020163L NO20020163L (no) 2002-01-11
NO328103B1 NO328103B1 (no) 2009-12-07

Family

ID=27513029

Family Applications (2)

Application Number Title Priority Date Filing Date
NO20020163A NO328103B1 (no) 1999-07-13 2002-01-11 Fremgangsmate for fremstilling av 2-amino-4-(4-fluorfenyl)-6-alkylpyrimidin-5-karboksylater og mellomprodukter derav
NO20092393A NO334937B1 (no) 1999-07-13 2009-06-23 Fremgangsmåte for fremstilling av N-cyano-N-alkylalkansulfonamider og 4-fenylpyrimidiner samt slike forbindelser

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO20092393A NO334937B1 (no) 1999-07-13 2009-06-23 Fremgangsmåte for fremstilling av N-cyano-N-alkylalkansulfonamider og 4-fenylpyrimidiner samt slike forbindelser

Country Status (17)

Country Link
US (3) US6579984B1 (no)
EP (1) EP1194414B1 (no)
JP (1) JP4649813B2 (no)
KR (1) KR100649927B1 (no)
CN (1) CN1164577C (no)
AT (1) ATE307120T1 (no)
AU (1) AU6266600A (no)
CA (1) CA2378782C (no)
CZ (1) CZ304307B6 (no)
DE (1) DE60023296T2 (no)
ES (1) ES2251392T3 (no)
HK (1) HK1046682B (no)
HU (1) HU228303B1 (no)
NO (2) NO328103B1 (no)
PL (1) PL211797B1 (no)
SK (1) SK285993B6 (no)
WO (1) WO2001004100A1 (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0003305D0 (en) * 2000-02-15 2000-04-05 Zeneca Ltd Pyrimidine derivatives
CA2453505C (en) * 2001-07-13 2011-04-19 Astrazeneca Uk Limited Preparation of aminopyrimidine compounds
GB0218781D0 (en) * 2002-08-13 2002-09-18 Astrazeneca Ab Chemical process
CA2509344C (en) 2002-12-16 2011-10-04 Astrazeneca Uk Limited Process for the preparation of pyrimidine compounds
GB0428328D0 (en) 2004-12-24 2005-02-02 Astrazeneca Uk Ltd Chemical process
EP2423195A1 (en) 2010-07-26 2012-02-29 LEK Pharmaceuticals d.d. Process for the preparation of key intermediates for the synthesis of statins or pharmaceutically acceptable salts thereof
PL2605652T3 (pl) 2010-08-18 2018-04-30 Samumed, Llc Diketony i hydroksyketony jako aktywatory szlaku sygnalizacji kateninowej
CA2901671C (en) 2013-02-22 2021-07-13 Samumed, Llc .gamma.-diketones as wnt/.beta. -catenin signaling pathway activators
CN103910644B (zh) * 2014-04-21 2015-06-24 广西师范大学 β-烯胺酮酯类化合物及其合成方法和应用
RU2727039C2 (ru) 2014-08-20 2020-07-17 СЭМЬЮМЕД, ЭлЭлСи Гамма-дикетоны для лечения и профилактики старения кожи и морщин
CN110483341A (zh) * 2019-07-23 2019-11-22 上海药明康德新药开发有限公司 一种1-氰基-n-甲基甲磺酰胺的合成方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4013706A (en) * 1973-11-14 1977-03-22 Sucreries Du Soissonnais Et Compagnie Sucriere Derivatives of substituted urea, acyl ureas, and sulphonyl ureas, and a process for producing the same
DE3717815A1 (de) * 1987-05-27 1988-12-15 Bayer Ag Fungizide mittel auf basis von substituierten cyanamiden
JP2648897B2 (ja) * 1991-07-01 1997-09-03 塩野義製薬株式会社 ピリミジン誘導体
JP3197971B2 (ja) * 1993-03-01 2001-08-13 塩野義製薬株式会社 5−カルボアルコキシピリミジン誘導体の合成方法

Also Published As

Publication number Publication date
DE60023296D1 (de) 2006-03-02
CZ200261A3 (cs) 2002-05-15
NO328103B1 (no) 2009-12-07
HK1046682A1 (en) 2003-01-24
CN1370151A (zh) 2002-09-18
HUP0202006A2 (hu) 2002-12-28
KR100649927B1 (ko) 2006-11-27
JP4649813B2 (ja) 2011-03-16
JP2003504359A (ja) 2003-02-04
NO334937B1 (no) 2014-07-21
SK285993B6 (sk) 2008-01-07
ES2251392T3 (es) 2006-05-01
CZ304307B6 (cs) 2014-02-26
CN1164577C (zh) 2004-09-01
EP1194414A1 (en) 2002-04-10
HU228303B1 (hu) 2013-03-28
US20040181065A1 (en) 2004-09-16
US6984757B2 (en) 2006-01-10
US20030199695A1 (en) 2003-10-23
EP1194414B1 (en) 2005-10-19
US6579984B1 (en) 2003-06-17
NO20092393L (no) 2002-01-11
SK222002A3 (en) 2002-06-04
ATE307120T1 (de) 2005-11-15
HK1046682B (zh) 2005-04-08
PL211797B1 (pl) 2012-06-29
CA2378782A1 (en) 2001-01-18
CA2378782C (en) 2009-11-10
KR20020012007A (ko) 2002-02-09
HUP0202006A3 (en) 2003-02-28
PL353058A1 (en) 2003-10-06
WO2001004100A1 (en) 2001-01-18
AU6266600A (en) 2001-01-30
NO20020163L (no) 2002-01-11
US6710178B2 (en) 2004-03-23
DE60023296T2 (de) 2006-07-20

Similar Documents

Publication Publication Date Title
NO20020163D0 (no) Fremgangsmåte for fremstilling av 2-amino-4-(4-fluorfenyl)-6- alkylpyrimidin-5-karboksylat
HUP0401248A2 (hu) Eljárás amino-pirimidin-vegyületek előállítására és új intermedierek
HUP0400451A2 (hu) Pirrolszármazékok és ezeket tartalmazó gyógyászati készítmények
PL326203A1 (en) (methylsulphonyl)phenyl-2-(5)-furanones as cox-2 inhibitors
DE69635609D1 (de) Nukleinsäure enthaltende zusammensetzung, herstellung und verwendung
PT1131318E (pt) Processo para a producao de pirazoles 5-substituidos utilizando ditietanos
DE69912581D1 (de) Biarylessigsäure-derivate und ihre verwendung als cox-2 inhibitoren
CY1111440T1 (el) 5-χλωρο-3-(4-μεθανοσουλφονυλφαινυλ)-6'-μεθυλ-[2,3']διπυριδινυλ σε καθαρη κρυσταλλικη μορφη και διαδικασια για συνθεση
ATE232873T1 (de) Phosphonsaürederivate als ptp-1b-inhibitoren
PT1049703E (pt) Aldeido do acido n-¬2-(5-benziloxicarbonilamino-6-oxo-2-(4-fluorofenil)-1,6-di-hidro-1-pirimidinil)acetoxil|-l-aspartico como inibidor da enzima de conversao da interleucina-1beta in vivo
HU0200705D0 (en) Pyridine-2,3-dicarboxylic acid diamides
BG105736A (en) 2,3,4,5-tetrahydro-1h-[1,4]benzodiasepine-3-hydroxamic acid as matrix metalloproteinase inhibitors
DE69813565D1 (de) Substituierte 3,3-diamino-2-propennitrile, ihre herstellung und verwendung
DK1121364T3 (da) Fremgangsmåde til fremstilling af epothilon B og derivater samt mellemprodukter til fremstilling deraf
NO20004919L (no) Fremgangsmåte for fremstilling av 5-hydroksybenzo[b]tiofen-3- karboksylsyrederivater
WO2000061729A3 (en) Regulation of the expression of transcriptional repressor genes using nucleic acid molecules
AU2002218422A1 (en) New desloratadine salts, process for their synthesis and pharmaceutical compositions thereof
NO20021727L (no) Fremgangsmåte for fremstilling av 3,4-metylen-dioksy- mandelisk syre
MY106363A (en) Carbamoyl indole derivatives having leukotriene antagonists properties
DE60204681D1 (de) Verfahren zur herstellung von 2-[4-(2,2,-dihalocyclopropyl)phenoxy]-alkansäuren und ihre estern
WO2001083423A3 (en) 2,6-diamino-6-methyl-heptanoic acid and derivatives, process for the preparation thereof and use thereof
ATE252566T1 (de) Herstellung von 2-(2-arylmorpholin-2- yl)ethanolderivaten und zwischenprodukte
DE59800860D1 (de) Wasserlösliche, flockbare und biologisch abbaubare hydroxyalkylcellulose-2-hydroxycarbonsäureester
EA200100155A3 (ru) Новые производные 6-амино или 6-гидразиносульфонил-3-хинолинилфосфоновой кислоты, способ их получения и содержащие их фармацевтические композиции
DK1196428T3 (da) 11-beta-aryl-17,17-spirothiolan-substituerede steroider

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees